PlainPharmaWatch

CMS Open Payments · Program Year 2024

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. reported $10,654,264.96 in payments to 20,498 physicians and teaching hospitals across 21,676 transactions.

See the rankings → How this is sourced
$10.7M
Total payments
21,676
Transactions
20,498
Recipients
+$1.9M
General Payments vs PY2023

Lexicon Pharmaceuticals, Inc. reported $10,654,264.96 in payments to 20,498 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #164 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $519.77 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Lexicon Pharmaceuticals, Inc. pairs top-10% payment volume with an unusually diversified payment pattern across a wide recipient base.

#164
of 1,925 companies
0.1%
of all US industry payments
0.0%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Lexicon Pharmaceuticals, Inc.'s CMS-reported General Payments increased by $1.9M (+297.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: LEXICON PHARMACEUTICALS, INC.PY2024: Lexicon Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$632.4KPY2024$2.5M
PY2023
$632,449.61
PY2024
$2,512,492.60

How Lexicon Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Lexicon Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$10,654,265 Top 8% higher than 92% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Lexicon Pharmaceuticals, Inc.

Rank #164 of 1,925 companies in CMS Open Payments for 2024 belongs to Lexicon Pharmaceuticals, Inc., which reported $10,654,264.96 across 21,676 transactions to 20,498 recipients - a comparatively small 0.1% slice of all industry payments reported nationwide for the year. Averages work out to $491.52 per transaction and $519.77 per recipient.

Of the 6 general-payment categories charted below, "Honoraria" is the largest at $1.3M across 484 transactions, 12.4% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Lexicon Pharmaceuticals, Inc. made 6 types of general payments. "Honoraria" is the largest category at $1.3M, 12.4% of the company's reported total.

How Lexicon Pharmaceuticals, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Honoraria$1.3M2. Food and Beverage$567.7K3. Consulting Fee$400.6K4. Travel and Lodging$199.2K5. Compensation for Services…$18.5K6. Space Rental or Facility …$1.8K
Payment Type Amount Transactions
Honoraria $1.3M 484
Food and Beverage $567.7K 19,120
Consulting Fee $400.6K 42
Travel and Lodging $199.2K 847
Compensation for Services Other Than Consulting $18.5K 3
Space Rental or Facility Fees $1.8K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $283,188.10 (11.3%) of $2,512,492.60 in this company's General Payments records across 9,018 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Lexicon Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

Judith Lea Swain$70.9KAmerico a Simonini$54.2KRodney a Samaan$54.1KMatthew Budoff$52.2KNorman Lepor$51.8K
  1. 1

    Judith Lea Swain

    $70,901.81 across 4 reported transactions

  2. 2

    Americo a Simonini

    $54,177.99 across 64 reported transactions

  3. 3

    Rodney a Samaan

    $54,102.23 across 81 reported transactions

  4. 4

    Matthew Budoff

    $52,169.34 across 9 reported transactions

  5. 5

    Norman Lepor

    $51,836.73 across 63 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $491.52. Average per recipient: $519.77.

Total Amount

$10,654,264.96

Avg per Transaction

$491.52

Avg per Recipient

$519.77

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Lexicon Pharmaceuticals, Inc. Share

0.1%

#164 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Lexicon Pharmaceuticals, Inc.

Sanofi-Aventis U.s. LLC

$10.7M 42,061 recipients

Ortho-Clinical Diagnostics, Inc.

$10.7M 232 recipients

Astellas Pharma US Inc

$10.6M 147,377 recipients

TG Therapeutics, Inc.

$10.7M 12,185 recipients

Alafair Biosciences, Inc.

$10.8M 704 recipients

Treace Medical Concepts, Inc.

$10.5M 10,486 recipients

Frequently Asked Questions

How much did Lexicon Pharmaceuticals, Inc. pay to physicians and hospitals in 2024? ▾
0.1% of all industry payments reported to CMS Open Payments for 2024 came from Lexicon Pharmaceuticals, Inc., totaling $10,654,264.96 across 21,676 transactions to physicians and hospitals.
How many physicians received payments from Lexicon Pharmaceuticals, Inc.? ▾
Averaging $519.77 per recipient, Lexicon Pharmaceuticals, Inc.'s 2024 payments reached 20,498 physicians and teaching hospitals.
What types of payments did Lexicon Pharmaceuticals, Inc. make? ▾
General payments from Lexicon Pharmaceuticals, Inc. span 6 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Honoraria" at $1.3M, representing 12.4% of the company's reported total.
How does Lexicon Pharmaceuticals, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Lexicon Pharmaceuticals, Inc. sits at #164 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Lexicon Pharmaceuticals, Inc.? ▾
Lexicon Pharmaceuticals, Inc.'s 21,676 transactions to 20,498 recipients in 2024 averaged $491.52 per transaction.
Where does the payment data for Lexicon Pharmaceuticals, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Lexicon Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.